CURE® Women's Cancers 2021 Special Issue

Balancing Cancer Screenings and COVID-19 Safety

March 25, 2021

Editor's Page

Although COVID-19 has shaken our lives in so many ways, it’s important to keep our health one of our top priorities while also staying safe. We must find widely acceptable ways to screen for cancer in this new era so that we don’t turn the clock back on the gains we have made in the past few decades.

Having the Ball in Your Court Helps You Fight Cancer

March 22, 2021


A three-time cancer survivor discusses the importance of genetic testing, listening to your body and teaching family members about your experiences to potentially protect them from future cancers.

Invasive Disease-Free Survival Improves With Perjeta Plus Standard Therapy in HER2-Positive Breast Cancer

February 16, 2021

Patents with HER2-positive breast cancer had a similar rate of overall survival with Perjeta plus chemotherapy and trastuzumab compared with placebo plus chemotherapy and trastuzumab, although longer follow-up is needed to determine whether a benefit exists in that area.